Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program

(NASDAQ:TLSA), BOSTON, Nov. 25, 2025 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies, today announced that its Phase 2 clinical trial evaluating intranasal foralumab in patients with amyotrophic lateral sclerosis (ALS) has been accepted for inclusion in the ALS MyMatch Program at the […]

BlackLine Issues Statement Regarding Shareholder Engagement

(NASDAQ:BL), LOS ANGELES, Nov. 25, 2025 (GLOBE NEWSWIRE) — BlackLine, Inc. (Nasdaq: BL) (“BlackLine” or the “Company”) today issued the following statement: The Company and members of the Board of Directors actively meet with company stockholders on a regular basis. More recently, these meetings have included Engaged Capital with whom management and independent directors have

Worksport Announces HD3 Heavy-Duty Tonneau Cover Now Selling to B2B Dealers Following October Production Launch

(NASDAQ:WKSP), Company Expands Dealer Offering with New Heavy-Duty Platform as COR and SOLIS Prepare for Initial Orders Opening November 28 West Seneca, New York, Nov. 25, 2025 (GLOBE NEWSWIRE) — Worksport Ltd. (NASDAQ: WKSP) (“Worksport” or the “Company”), a U.S.-based innovator in advanced manufacturing, clean energy technologies and automotive accessories, serving both consumer and reseller

PodcastOne (Nasdaq: PODC) Aligns with Former New York Yankees Outfielder Clint Frazier for Multi-Year Exclusive Distribution Rights for Life After the Show Podcast

(NASDAQ:PODC), LOS ANGELES, Nov. 25, 2025 (GLOBE NEWSWIRE) — PodcastOne (Nasdaq: PODC), a leading publisher and podcast sales network, announced today that it has entered into a multi-year agreement with former New York Yankees outfielder Clint Frazier for the exclusive distribution rights to Frazier's Life After the Show podcast. Life After the Show episodes drop

Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access

(NASDAQ:IART), PRINCETON, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, commends the Centers for Medicare & Medicaid Services (CMS) on its Calendar Year 2026 Medicare Physician Fee Schedule and Outpatient Prospective Payment System rules. All Integra dermal regenerative templates, decellularized dermal scaffolds and amniotic

Reliance Global Group (RELI) Consolidates Digital Asset Treasury Into Zcash (ZEC)

(NASDAQ:RELI),(NASDAQ:RELIW), LAKEWOOD, NJ, Nov. 25, 2025 (GLOBE NEWSWIRE) — Reliance Global Group, Inc. (Nasdaq: RELI) (“Reliance”, “we” or the “Company”) today announced that it has completed a strategic realignment of its Digital Asset Treasury (“DAT”), by consolidating its digital asset position into Zcash (ZEC). The Company has fully exited its prior holdings and reallocated the

American Rebel Holdings, Inc. (NASDAQ: AREB) Expands Kroger Footprint as Downtown Nashville Kroger Flagship Store #502 Adds American Rebel Light Beer

(NASDAQ:AREB),(NASDAQ:AREBW), Placement of 16oz American Rebel Light Beer cans in Kroger Store #502 advances the Company's distribution-first growth plan in its home market, bringing America's fastest growing patriotic, all natural low calorie light beer to another high profile Tennessee location Nashville, TN, Nov. 25, 2025 (GLOBE NEWSWIRE) — American Rebel Holdings, Inc. (NASDAQ: AREB), maker

Xenon to Present New Azetukalner OLE Study Data in Epilepsy at AES 2025

(NasdaqGM:XENE), Seven posters to be presented, including new X-TOLE OLE data supporting the ability to attain and regain extended periods of seizure freedom with long-term use of azetukalner Data will also highlight the impact of depression and burden of titration on patients with epilepsy, as well as new pre-clinical data from the Company's NaV1.1 program

LIXTE Biotechnology Acquires Liora Technologies’ Proprietary Proton Therapy Platform for Cancer Treatment

(NASDAQ:LIXT),(NASDAQ:LIXTW), Located at the Daresbury site of the renowned UK-based Science and Technology Facilities Council (STFC), with $300+ million invested to date in developing the technology BOCA RATON, Fla., Nov. 25, 2025 (GLOBE NEWSWIRE) — LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT) a biotech company focused on advancing cancer treatments, today announced

Scroll to Top